Is Sermorelin Legal in Texas? How to Access It Legally

Print or save as PDF

Key numbers

  • 30 micrograms per kgStudied pediatric dose given once daily under the skin at bedtime; not a recommended doseSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 0.5 mgStudied dose in older men given twice daily under the skin; no sermorelin dose is approvedSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 74%Share of evaluable children who were good responders at 6 months in the one-year pediatric studySource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026

See the public record for Sermorelin

  • FDA approval / None; Geref's approvals withdrawn effective June 18, 2009 [1]
  • Sold today / Compounded sermorelin, not FDA-approved [2]
  • Geref's approved uses / Pediatric growth hormone deficiency and a pituitary test only [1]
  • Not approved for / Adults, anti-aging, weight loss or athletic performance [1]
  • FDA safety-risk bulk list / Sermorelin not listed (content dated 04/22/2026) [3]
  • Outsourcing-facility bulk list / Category 1, under evaluation (updated March 21, 2025) [4]
  • State-pharmacy bulk list / No category (updated May 14, 2026) [5]
  • Sport / WADA S2.2.4, prohibited at all times [6]

What Is Sermorelin's Federal Status?

Sermorelin is a 29-amino-acid analogue of growth hormone-releasing hormone that prompts the pituitary to release the body's own growth hormone; it is not growth hormone [7].

Two Geref products held the only FDA approvals: a 0.05 mg ampule approved December 28, 1990 for evaluating pituitary growth hormone secretion, and 0.5 mg and 1 mg vials approved September 26, 1997 for treating idiopathic growth hormone deficiency in children with growth failure [1]. The manufacturer discontinued both in 2008 and asked FDA to withdraw the applications; FDA withdrew them effective June 18, 2009, and in March 2013 determined Geref had not been withdrawn for reasons of safety or effectiveness [1][8]. Those two remain the only sermorelin applications in Drugs@FDA [8]. Geref was not approved for adults, anti-aging, weight loss or athletic performance [1].

What Do FDA's Compounding Lists Say?

Sermorelin is not on FDA's list of bulk substances that may present significant safety risks when compounded (content dated 04/22/2026) [3]. On the list of bulk substances nominated for outsourcing facilities — the large, FDA-registered compounders — sermorelin acetate is in category 1, under evaluation, marked as a component of FDA-approved drugs (updated March 21, 2025) [4]. It appears in no category on FDA's list for state-licensed pharmacies and physicians, updated May 14, 2026 [5], and is not among the six peptides in HHS's October 2026 draft enforcement-discretion policy [9].

How Is Sermorelin Supplied?

Compounding can take place in state-licensed pharmacies, federal facilities, physicians' offices or FDA-registered outsourcing facilities [10]. FDA says state boards of pharmacy generally have primary responsibility for day-to-day oversight of state-licensed pharmacies, while outsourcing facilities are primarily overseen by FDA [10]. Compounded drugs are not FDA-approved and FDA does not verify their safety, effectiveness or quality before marketing [2]; FDA says compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug, and that poor compounding practices can yield a contaminated drug or one with too much or too little active ingredient [10].

Questions worth asking

Choose the questions you want to keep

What Do the Studies Show?

No sermorelin product is approved today, so there is no current approved dose [1]. Study doses were 30 micrograms per kg once daily under the skin at bedtime in children [11] and 0.5 mg or 1 mg twice daily in older men [12].

In the one-year pediatric study, 110 previously untreated children were treated and 86 were evaluable; mean height velocity rose from 4.1 cm per year at baseline to 8.0 cm per year at 6 months and 7.2 cm per year at 12 months, and 74% were good responders at 6 months [11]. Fasting glucose did not change, IGF-I was not excessively raised, and the drug was well tolerated overall [11].

The 10 healthy older men (mean age 68) received 0.5 mg and 1 mg under the skin twice daily for 14 days each, in random order, alongside 9 men of mean age 26; at the higher dose, 24-hour growth hormone and IGF-I rose to levels not significantly different from the younger men, though the study measured hormone levels rather than clinical outcomes [12].

FDA recalls of sermorelin products by Texas firms, 2013 to 2026

9 recall events in FDA records that name sermorelin and were started by firms in Texas, from 2013 to 2026. Each links to the record itself.

6 of 9 events shown

  1. Recall

    Houston Rx LLC: recall of one sermorelin product

    Class II recall, now ongoing. Reason FDA lists: Lack of process control.

    Source: openFDA drug enforcement report, recall D-0041-2027

  2. Recall

    North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding: recall of 2 sermorelin products

    Class II recall, now terminated. Reason FDA lists: Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

    Source: openFDA drug enforcement report, recall D-0777-2022

  3. Recall

    Vita Pharmacy, LLC dba Talon Compounding Pharmacy: recall of 3 sermorelin products

    Class II recall, now terminated. Reason FDA lists: Lack of assurance of sterility.

    Source: openFDA drug enforcement report, recall D-0144-2022

  4. Recall

    Innoveix Pharmaceuticals Inc: recall of one sermorelin product

    Class II recall, now terminated. Reason FDA lists: Lack of Sterility Assurance.

    Source: openFDA drug enforcement report, recall D-0159-2020

  5. Recall

    Pharm D Solutions, LLC: recall of 6 sermorelin products

    Class II recall, now terminated. Reason FDA lists: Lack of Sterility Assurance.

    Source: openFDA drug enforcement report, recall D-1332-2019

  6. Recall

    Pharm D Solutions, LLC: recall of 7 sermorelin products

    Class II recall, now terminated. Reason FDA lists: Lack of Assurance of Sterility.

    Source: openFDA drug enforcement report, recall D-0181-2019

Events checked against their sources Nov 14, 2026.

Is sermorelin legal in Texas?
No sermorelin product is FDA-approved: the only approved products, the Geref versions, were withdrawn in 2009, so today's supply is compounded and not reviewed by FDA for safety, effectiveness or quality [1][2]. Federal information does not establish a Texas-specific rule for sermorelin; FDA says state boards of pharmacy generally oversee state-licensed pharmacies [10].
Why was Geref taken off the market?
The manufacturer discontinued it in 2008 and asked FDA to withdraw the applications; FDA withdrew them in 2009 and in March 2013 determined Geref was not withdrawn for safety or effectiveness reasons [1][8].
Can athletes use sermorelin?
WADA names sermorelin in S2.2.4 of its 2026 Prohibited List, prohibited at all times, in and out of competition [6].
What dose of sermorelin is approved?
None, because no sermorelin product is approved today [1]. Studied doses were 30 micrograms per kg once daily at bedtime in children [11] and 0.5 or 1 mg twice daily in older men [12]; neither is a recommended dose.

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

Is sermorelin FDA-approved?

No. Geref, the only FDA-approved sermorelin product, was discontinued in 2008 and FDA withdrew its approvals effective June 18, 2009. Sermorelin sold today is compounded, and FDA does not verify its safety, effectiveness or quality before marketing.

Do you need a prescription for peptides in Texas?

Federal information does not establish a Texas-specific rule for sermorelin. FDA says state boards of pharmacy generally have primary responsibility for day-to-day oversight of state-licensed pharmacies, while outsourcing facilities are primarily overseen by FDA.

Show all 12 referencesHide references
  1. Federal Register :: Request Access.
  2. Official web page.
  3. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
  4. U.S. Food and Drug Administration.
  5. U.S. Food and Drug Administration.
  6. World Anti-Doping Agency.
  7. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
  8. U.S. Food and Drug Administration.
  9. Official web page.
  10. Compounding and the FDA: Questions and Answers | FDA.
  11. Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
  12. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
Sermorelin legal Texas: evidence summary chart
Image: HealthRX.com. Full sermorelin legal Texas guide and sources at healthrx.com/peptide-legal-sermorelin.